<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-QY6W6JXX</identifier><date>2021</date><creator>Borštnar, Simona</creator><relation>documents/doc/Q/URN_NBN_SI_doc-QY6W6JXX_001.pdf</relation><relation>documents/doc/Q/URN_NBN_SI_doc-QY6W6JXX_001.txt</relation><format format_type="issue">5</format><format format_type="volume">72</format><format format_type="type">article</format><format format_type="extent">str. 348-353</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">83614467</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-QY6W6JXX</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">ginekološki raki</subject><subject language_type_id="slv">rak dojk</subject><subject language_type_id="slv">rak jajčnikov</subject><subject language_type_id="slv">rak materničnega vratu</subject><title>Rak pri ženskah</title><title>Women's cancer</title></Record>